Suppr超能文献

用于检测低水平活性巴那斯酶突变体的体内系统。

In vivo system for the detection of low level activity barnase mutants.

作者信息

Jucovic M, Hartley R W

机构信息

Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Protein Eng. 1995 May;8(5):497-9. doi: 10.1093/protein/8.5.497.

Abstract

We report the design of a new tightly controlled barnase system which allows the existence of the barnase gene in host cells without a signal sequence. When expression of barnase is turned on by gene inversion in vivo, the lethal effect of barnase (or its mutants) is not compromised either by coexpression of its polypeptide inhibitor (barstar), or by extracellular secretion. This serves as a rapid, sensitive in vivo test for the detection of any very low residual activity of the barnase mutants. Active-site mutants His102Lys, Glu73Asp and Arg87Lys, and a mutant which greatly reduces the stability and yield of protein, Arg83Lys, produce enough activity to be detectable by this test. In contrast, when expressed on a secretion vector, these mutants do not yield detectable activity in a solution assay. Truly inactive mutants, such as those of His102 to Gly, Ala or Leu, were completely harmless when expressed in this system.

摘要

我们报道了一种新型严格控制的芽孢杆菌RNA酶(barnase)系统的设计,该系统允许芽孢杆菌RNA酶基因在宿主细胞中无信号序列存在。当体内通过基因倒置开启芽孢杆菌RNA酶表达时,芽孢杆菌RNA酶(或其突变体)的致死效应既不会因共表达其多肽抑制剂(芽孢杆菌RNA酶抑制剂,barstar)而受损,也不会因细胞外分泌而受损。这可作为一种快速、灵敏的体内检测方法,用于检测芽孢杆菌RNA酶突变体的任何极低残留活性。活性位点突变体His102Lys、Glu73Asp和Arg87Lys,以及一个极大降低蛋白质稳定性和产量的突变体Arg83Lys,产生的活性足以通过该检测方法检测到。相比之下,当在分泌载体上表达时,这些突变体在溶液检测中未产生可检测到的活性。真正无活性的突变体,如His102突变为Gly、Ala或Leu的突变体,在该系统中表达时完全无害。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验